Market Overview

Janney Capital Initiates Coverage on Vertex Pharmaceuticals Incorporated at Buy, Announces $54.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for VRTX

DateFirmActionFromTo
Nov 2016BarclaysDowngradesOverweightEqual-Weight
Nov 2016Janney CapitalInitiates Coverage OnNeutral
Nov 2016William BlairDowngradesOutperformMarket Perform

View More Analyst Ratings for VRTX
View the Latest Analyst Ratings

Posted-In: News Analyst Ratings

 

Related Articles (VRTX)